Matches in Nanopublications for { ?s ?p "[Therefore, testing for KRAS and BRAF mutations could be a valuable adjunct in improving both prognosis and outcome stratification among patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP681473.RAgTk8dEeSc8DcM_7LWKDqYuIN9CdTgHMGSw9OSDYSFto130_assertion description "[Therefore, testing for KRAS and BRAF mutations could be a valuable adjunct in improving both prognosis and outcome stratification among patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681473.RAgTk8dEeSc8DcM_7LWKDqYuIN9CdTgHMGSw9OSDYSFto130_provenance.
- NP1120663.RASoWBcnqdhqKXgeRWBJUTBxSCQBVarL47uwZMpW0mhIU130_assertion description "[Therefore, testing for KRAS and BRAF mutations could be a valuable adjunct in improving both prognosis and outcome stratification among patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1120663.RASoWBcnqdhqKXgeRWBJUTBxSCQBVarL47uwZMpW0mhIU130_provenance.
- NP272428.RA-bohCGGQESUiTo3RpmgzTP23r9WgduuFJisnefVtFpE130_assertion description "[Therefore, testing for KRAS and BRAF mutations could be a valuable adjunct in improving both prognosis and outcome stratification among patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272428.RA-bohCGGQESUiTo3RpmgzTP23r9WgduuFJisnefVtFpE130_provenance.
- NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_assertion description "[Therefore, testing for KRAS and BRAF mutations could be a valuable adjunct in improving both prognosis and outcome stratification among patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527763.RAHaRiTW-GTzlgMluatQzVnrTd5gizzv7rdZw9suLXnN8130_provenance.
- NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_assertion description "[Therefore, testing for KRAS and BRAF mutations could be a valuable adjunct in improving both prognosis and outcome stratification among patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_provenance.